Table of Contents
Volume 4 | Issue 5
Publication Date: January 2005
Abstract
No Access
Pay-Per View
Full Text
Add to Cart
Editorial | ||
 292 |
The Development of the FOLFOX Regimens as a Treatment Standard of Advanced Colorectal Cancer Edward Chu |
|
Researches in Brief | ||
296-299 |
Evolution of FOLFOX Regimens in the Treatment of Advanced Colorectal Cancer G. Kesava Reddy, Angelia D. Gibson, Nancy Price, Edward Chu |
|
300-301 |
The Addition of Bevacizumab to FOLFOX4 Prolongs Survival in Relapsed Colorectal Cancer: Interim Data from the ECOG 3200 Trial G. Kesava Reddy, Vinay K. Jain |
|
Comprehensive Reviews | ||
302-312 |
Staging of Colorectal Cancer: Past, Present, and Future Janet K. Horton, Joel E. Tepper |
|
313-319 |
Colorectal Cancer in Patients with Inflammatory Bowel Disease Parsia A. Vagefi, Walter E. Longo |
|
320-324 |
Lymphatic Mapping and Sentinel Node Analysis in Colon Cancer Steve R. Martinez, Anton J. Bilchik |
|
Original Contributions | ||
325-331 |
5-Fluorouracil–Based Chemotherapy for Advanced Colorectal Cancer in Elderly Patients: A North Central Cancer Treatment Group Study Stacy D’Andre, Daniel J. Sargent, Stephen S. Cha, Thomas R. Buroker, John W. Kugler, Richard M. Goldberg, Michael J. O’Connell, Michael A. Poon |
|
332-335 |
Long-Term Results of Local Excision with and Without Chemoradiation for Adenocarcinoma of the Rectum Stacy Wentworth, Gregory B. Russell, Immanuel I. Turner, Edward A. Levine, Girish Mishra, Gregory S. Waters, A. William Blackstock |
|
Translational Medicine | ||
336-343 |
Synergistic Antitumor Activity of Capecitabine in Combination with Irinotecan Shousong Cao, Farukh A. Durrani, Youcef M. Rustum |
|
Commentary | ||
344 |
Importance of Preclinical Investigations of the Integration of Capecitabine into Polychemotherapy Regimens Romano Danesi, Guido Bocci, Antonello Di Paolo |
|
